Alzheimer's researcher receives high honour
16 August, 2007A neuroscientist was awarded the Victoria Prize, last night, for his groundbreaking research into Alzheimer's disease.
New research provides hope for childhood cancer sufferers
17 July, 2007Scientists investigating drug therapies for children with Acute Lymphoblastic Leukaemia (ALL) have presented new data demonstrating for the very first time that a small molecule called ABT-737 can increase the effectiveness of standard therapies.
Discovering dementia's molecular structure
06 July, 2007The Australian Synchrotron is due to open for general use later this year. The synchrotron will create beams of laser-like intense light that can be used for looking at materials in sub-microscopic detail and manufacturing small, precise materials
Cold sore suppression
26 June, 2007After the initial infection, the Herpes simplex 1 (HSV-1) virus usually remains in the body, hiding out in nearby nerve cells where the victim’s immune defenses cannot reach it, causing no symptoms at all.
Alzheimer’s biomarkers
21 June, 2007Scientists collaborating at Cornell University and Weill Cornell Medical College have identified a panel of 23 protein biomarkers in cerebrospinal fluid that acts as a neurochemical ‘fingerprint’, which doctors might use someday to identify patients living with Alzheimer’s disease.
Students devise an oral rotavirus vaccine
19 June, 2007A group of Johns Hopkins undergraduate biomedical engineering students have developed a rotavirus vaccine for infants that dissolves in the mouth like a popular breath freshener.
TB research wins Victorian medical award
05 June, 2007Melbourne epidemiologist Dr Helen Cox has won the 2007 Premier’s Award for Medical Research for her work on drug-resistant tuberculosis (TB).
Contract facility to speed medical research
30 May, 2007Australia's first preclinical contract R&D facility, TetraQ, was officially launched today to help speed the movement of medicines out of the laboratory and into the marketplace.
Staphylococcus aureus vaccine on track
29 May, 2007Austrian company Intercell has announced the completion of the phase I study of its Staphylococcus aureus vaccine.
Federal funding for a medical research powerhouse
09 May, 2007The federal government announced yesterday that it will back the development of a Brisbane-based major research centre, designed to test and produce new drugs for the medical industry.
Minority groups not genetically prone to diabetes
19 April, 2007A study by Australian and US researchers is helping dispel the 40-year-old ‘thrifty genotype theory’ – that certain minority groups are genetically prone to diabetes.
League greats tackle melanoma research
13 April, 2007The University of Queensland (UQ) has received a $48,000 donation to its cancer research institute from cancer charity group, Mardi Jackson Foundation.
Australian scientists identify cancer cells
30 March, 2007Australian scientists have identified the leukaemia cells responsible for causing relapse after treatment in common childhood cancer.
Antibiotic resistance in plague
21 March, 2007The ability to resist many of the antibiotics used against plague has been found so far in only a single case of the disease in Madagascar. But because the same ability is present in other kinds of bacteria from a broad range of livestock, antibiotic resistance could potentially spread to other Yersinia pestis and also other bacterial pathogens.
Australia awards cervical cancer vaccine developer
07 March, 2007The University of Queensland (UQ) professor behind the world’s first cervical cancer vaccine received one of Australia’s most prestigious medical awards last night.
